Latest News

Cannabis constituent has no effect on multiple sclerosis progression, study shows

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis, shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Using cerebral protection device during transcatheter aortic valve replacement can cut number of cerebral lesions

  • Master regulator of cells' heat shock response found, pointing to new potential targets for neurodegenerative diseases and cancer

  • Researchers urge psychologists to see institutional betrayal

  • Web-based training can reduce campus rape, study concludes

  • Mobility in cancer patients with malignant spinal cord compression

  • Slowed processing speed linked with executive deficits in multiple sclerosis

  • Neural compensation in people with Alzheimer's-related protein

  • Measuring modified protein structures: New approach

  • Identifying a better message strategy for dissuading smokers: Add the positive

  • Concept of time may predict impulsive behavior, research finds

  •